Morgans names 2 ASX shares to buy post-results

Analysts at Morgans have just named these ASX shares as buys…

The team at Morgans has been working hard this month analysing the seemingly endless stream of results that have been released.

Two companies that caught the broker's eyes recently are listed below. Here's why it thinks investors should be buying these ASX shares post-results:

Two brokers pointing and analysing a share price.

Image source: Getty Images

Accent Group Ltd (ASX: AX1)

The first ASX share that Morgans is tipping as a buy is footwear retailer Accent.

While FY 2022 was a difficult year for the company, the broker was pleased to see that FY 2023 has started positively. And with management aiming to stop discounting and sell at full price, its analysts see scope for margin improvements.

All in all, it feels this makes the Accent share price undervalued at current levels. Morgans has upgraded its shares to an add rating with a $2.00 price target. It commented:

We upgrade from Hold to Add with an increased target price of $2.00. With customer activity showing no signs of a pullback so far in FY23 and with demand for new (and often higher priced) products running strong over the past 8-12 weeks, we have become more positive on the immediate prospects for sales growth.

AX1's renewed focus on selling at full price will, in our view, support a recovery in the gross profit margin in FY23 back towards historical averages. We welcome AX1's moderation of the pace of its store rollout in favour of a more selective expansion strategy focused on return on investment. We see AX1 as undervalued at the current share price.

New Hope Corporation Limited (ASX: NHC)

Another ASX share that Morgans is bullish on is coal miner New Hope. The broker was pleased with its recent update and notes that coal prices continue to surprise to the upside.

In light of this and the strong free cash flow the company is generating, it suspects that a re-rating could be in order in the near future. Particularly given its favourable dividend outlook.

Morgans has retained its add rating with an improved price target of $5.50. It commented

4Q Production/Sales were more resilient to disruption than we had feared. Coal prices continue to surprise, driving further EPS/ valuation upgrades. Valuation/target adjusts to (login to view). We think NHC can re-rate as the market awakens to the sheer scope of current cash flows and ongoing dividend upside potential. ADD.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Couple using their digital tablet together.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Why the Paladin Energy share price "doesn't make sense"

This uranium stock could be set for a major re-rating.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »

Man using his device in an airport.
Broker Notes

This high-quality ASX 200 share could rise 60%

A leading broker expects a good yield and major upside from this stock.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Broker Notes

Trading near 12-month lows, this ASX retailer could be set for a 54% gain

This baby goods retailer still has ample room to grow.

Read more »